Docetaxel: a review of its use in metastatic breast cancer.

@article{LysengWilliamson2005DocetaxelAR,
  title={Docetaxel: a review of its use in metastatic breast cancer.},
  author={K. Lyseng-Williamson and C. Fenton},
  journal={Drugs},
  year={2005},
  volume={65 17},
  pages={
          2513-31
        }
}
Docetaxel (Taxotere), a cytotoxic taxane, is an antimicrotubule agent effective in the treatment of patients with breast cancer. The clinical profile of docetaxel as an effective cytotoxic agent in the treatment of metastatic breast cancer is well established. As yet, no single standard regimen has been identified as optimal for the treatment of patients with metastatic breast cancer after failure of prior chemotherapy. However, the efficacy of docetaxel monotherapy administered every 3 weeks… Expand
Chemotherapy and targeted agents for elderly women with advanced breast cancer.
Docetaxel: in gastric cancer.
Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro.
Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 77 REFERENCES
Docetaxel: an update of its use in advanced breast cancer.
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
  • S. Chan, K. Friedrichs, +20 authors J. Crown
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1999
...
1
2
3
4
5
...